AquaBounty Announced Plans to Cease Fish Farming Operations
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
On Dec. 10, 2024, the Pan American Health Organization (PAHO) reported on three transmissible diseases affecting the Region…
On Nov. 14, 2024, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention…
On Aug. 23, 2024, the World Health Organization (WHO) reported an outbreak of Oropouche virus (OROV) in the…
On May 15, 2024, researchers at Brazil’s Federal University of São Paulo announced they had found ancient herpes…
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…
On May 15, 2023, Brazil, the world’s top chicken exporter, for the first time confirmed Highly Pathogenic Avian…
On Mar. 31, 2022, researchers in Brazil reported that a study of COVID-19 patients at 12 clinics that…
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…
On Jan. 18, 2022, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
On Aug. 26, 2021, Inovio Pharma announced that it had received regulatory authorization from Brazil’s ANVISA (Agencia Nacional…
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
On Jun. 1, 2021, AquaBounty Technologies announced the regulatory approval of the Company’s GE Atlantic salmon by Brazil’s…
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
On May 20, 2021, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
On May 18, 2021, GlaxoSmithKline and Medicago reported positive interim Phase 2 clinical trial safety and immunogenicity data…
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…
On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…
On Apr. 19, 2021, the Broad Institute of MIT in partnership with the Centers for Disease Control and…